Browsing by Author Venetsanopoulou, A. I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date???itemlist.???
Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphismChatzikyriakidou, A.; Georgiou, I.; Voulgari, P. V.; Venetsanopoulou, A. I.; Drosos, A. A.24-Nov-2015-
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled studyNikas, S. N.; Voulgari, P. V.; Alamanos, Y.; Papadopoulos, C. G.; Venetsanopoulou, A. I.; Georgiadis, A. N.; Drosos, A. A.24-Nov-2015-
Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003Alamanos, Y.; Tsifetaki, N.; Voulgari, P. V.; Venetsanopoulou, A. I.; Siozos, C.; Drosos, A. A.24-Nov-2015-
Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experienceVoulgari, P. V.; Venetsanopoulou, A. I.; Epagelis, E. K.; Alamanos, Y.; Takalou, I.; Drosos, A. A.24-Nov-2015-
Persistent clinical response of infliximab treatment, over a 4-year period in ankylosing spondylitisVenetsanopoulou, A. I.; Voulgari, P. V.; Alamanos, Y.; Papadopoulos, C. G.; Markatseli, T. E.; Drosos, A. A.24-Nov-2015-
Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term studyVoulgari, P. V.; Venetsanopoulou, A. I.; Exarchou, S. A.; Alamanos, Y.; Tsifetaki, N.; Drosos, A. A.24-Nov-2015-